journal article·2025-04Open access

EIF4A3‐Mediated Biogenesis of CircFADS1 Promotes the Progression of Hepatocellular Carcinoma via Wnt/β‐Catenin Pathway

Lei Tang, Yang Ji, Chuangye Ni, Zhenggang Xu, Yanjun Shen, Hao Lu, Chuanyong Zhang, Shikun Yang

Advanced Science· Volume 12· Issue 14

Abstract

Abstract Mounting research indicates that circRNAs are pivotal elements in tumorigenesis and progression. Understanding the mechanisms by which circRNAs function in tumors is crucial for identifying undiscovered diagnostic and treatment targets. This research centers on unraveling the mechanisms by which the novel circRNA, circFADS1, influences hepatocellular carcinoma (HCC) progression. CircFADS1 shows elevated expression in HCC and is linked to unfavorable prognosis. Functionally, circFADS1 overexpression accelerates HCC progression through inducing HCC proliferation and inhibited apoptosis. Mechanistically, RNA‐seq analysis demonstrates its connection to the Wnt/β‐catenin pathway. Moreover, circFADS1 interacts with GSK3β and promotes its ubiquitination and degradation by recruiting the ubiquitin ligase RNF114 while EIF4A3 facilitates the biogenesis of circFADS1. Additionally, circFADS1 is closely linked to lenvatinib resistance. Overall, this study reveals that circFADS1 regulates GSK3β function, influencing the progression of hepatocellular carcinoma. The EIF4A3/circFADS1/GSK3β/β‐catenin axis is discovered to hold promise as a novel therapeutic target for hepatocellular carcinoma, while circFADS1 is also a significant factor in lenvatinib resistance.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Circular RNAs in diseases · MicroRNA in disease regulation · RNA modifications and cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hepatobiliary Center The First Affiliated Hospital of Nanjing Medical University Key Laboratory of Liver Transplantation Chinese Academy of Medical Sciences NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University) No. 300 Guangzhou Road Nanjing Jiangsu 210029 China

Medical College Yangzhou University Yangzhou Jiangsu 225009 China

Funding

National Natural Science Foundation of China

References (43)

Show source-provided references
1. 10.3322/caac.2183410.3322/caac.21834 ↗
2. 10.1111/liv.1281810.1111/liv.12818 ↗
3. 10.1016/j.ijsu.2020.04.04310.1016/j.ijsu.2020.04.043 ↗
4. 10.1038/s41392-020-00264-x10.1038/s41392-020-00264-x ↗
5. 10.1038/s41571-018-0073-410.1038/s41571-018-0073-4 ↗
6. 10.1038/s41576-019-0158-710.1038/s41576-019-0158-7 ↗
7. 10.1038/d41586-023-03058-710.1038/d41586-023-03058-7 ↗
8. 10.1038/s41571-021-00585-y10.1038/s41571-021-00585-y ↗
9. 10.1186/s12943-017-0663-210.1186/s12943-017-0663-2 ↗
10. 10.1080/21655979.2022.203640610.1080/21655979.2022.2036406 ↗
11. 10.1186/s12943-021-01383-x10.1186/s12943-021-01383-x ↗
12. 10.1038/s41467-023-40212-110.1038/s41467-023-40212-1 ↗
13. 10.1186/s13046-022-02494-z10.1186/s13046-022-02494-z ↗
14. 10.3389/fonc.2022.87851310.3389/fonc.2022.878513 ↗
15. 10.1261/rna.043687.11310.1261/rna.043687.113 ↗
16. 10.1038/s41392-021-00701-510.1038/s41392-021-00701-5 ↗
17. 10.3389/fimmu.2019.0229310.3389/fimmu.2019.02293 ↗
18. 10.1021/acs.jmedchem.4c0058310.1021/acs.jmedchem.4c00583 ↗
19. 10.1038/s41580-020-0243-y10.1038/s41580-020-0243-y ↗
20. 10.1016/j.trecan.2020.01.01210.1016/j.trecan.2020.01.012 ↗
21. 10.1038/srep3498510.1038/srep34985 ↗
22. 10.1038/s41467-017-01216-w10.1038/s41467-017-01216-w ↗
23. 10.1038/s41392-020-0111-410.1038/s41392-020-0111-4 ↗
24. 10.1038/nsmb.278010.1038/nsmb.2780 ↗
25. 10.1186/s12943-022-01653-210.1186/s12943-022-01653-2 ↗
26. 10.1016/j.cell.2015.02.01410.1016/j.cell.2015.02.014 ↗
27. 10.1038/s41467-023-35998-z10.1038/s41467-023-35998-z ↗
28. 10.1080/15476286.2015.112806510.1080/15476286.2015.1128065 ↗
29. 10.1016/j.semcancer.2020.12.02610.1016/j.semcancer.2020.12.026 ↗
30. 10.1186/s13045-021-01145-810.1186/s13045-021-01145-8 ↗
31. 10.1038/onc.2016.30410.1038/onc.2016.304 ↗
32. 10.1172/JCI15451510.1172/JCI154515 ↗
33. 10.1038/s41417-022-00489-810.1038/s41417-022-00489-8 ↗
34. 10.1016/j.canlet.2008.05.04510.1016/j.canlet.2008.05.045 ↗
35. 10.7150/jca.6203310.7150/jca.62033 ↗
36. 10.1126/sciadv.adg775210.1126/sciadv.adg7752 ↗
37. 10.1007/s40265-019-01116-x10.1007/s40265-019-01116-x ↗
38. 10.2174/156800962266622042811132710.2174/1568009622666220428111327 ↗
39. 10.1158/0008-5472.CAN-21-414010.1158/0008-5472.CAN-21-4140 ↗
40. 10.1158/0008-5472.CAN-22-096310.1158/0008-5472.CAN-22-0963 ↗
41. 10.1080/15548627.2022.211789310.1080/15548627.2022.2117893 ↗
42. 10.1186/s12943-020-01281-810.1186/s12943-020-01281-8 ↗
43. 10.1111/j.1525-1594.2007.00524.x10.1111/j.1525-1594.2007.00524.x ↗